(Q48108751)

8 February 2018

title

Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor? (English)

1 reference

8 February 2018

author

Marieke Wichers

7

1 reference

8 February 2018

Harry W M Steinbusch

6

object named as

Harry W M Steinbusch

1 reference

8 February 2018

Jim van Os

3

object named as

Jim van Os

1 reference

8 February 2018

1

Gunter Kenis

1 reference

8 February 2018

author name string

Jos Prickaerts

2

1 reference

8 February 2018

Ger H Koek

4

1 reference

8 February 2018

Geert Robaeys

5

1 reference

8 February 2018

publication date

29 July 2010

1 reference

8 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

8 February 2018

volume

14

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

247-253

1 reference

8 February 2018

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Cytokines and major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Cytokines sing the blues: inflammation and the pathogenesis of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Chronic corticosterone manipulations in mice affect brain cell proliferation rates, but only partly affect BDNF protein levels

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Permeability of the blood-brain and blood-spinal cord barriers to interferons.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Transport of brain-derived neurotrophic factor across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Interferon-induced depression: strategies in treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Critical role of brain-derived neurotrophic factor in mood disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Salivary cortisol levels in children adopted from romanian orphanages

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

A neurotrophic model for stress-related mood disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

Treatment of cytokine-induced depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000830

7 January 2021

10.1017/S1461145710000830

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018